Heart Test Laboratories Stock Analysis

HSCS Stock  USD 4.03  0.03  0.74%   
Heart Test Laboratories is overvalued with Real Value of 3.73 and Target Price of 3.6. The main objective of Heart Test stock analysis is to determine its intrinsic value, which is an estimate of what Heart Test Laboratories is worth, separate from its market price. There are two main types of Heart Test's stock analysis: fundamental analysis and technical analysis.
The Heart Test stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Heart Test is usually not traded on Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day. Heart Stock trading window is adjusted to America/New York timezone.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Heart Test Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Heart Stock Analysis Notes

About 16.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.81. Some equities with similar Price to Book (P/B) outperform the market in the long run. Heart Test Laboratories recorded a loss per share of 35.0. The entity had not issued any dividends in recent years. The firm had 1:100 split on the 17th of May 2024. Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company was incorporated in 2007 and is headquartered in Southlake, Texas. Heart Test operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. To learn more about Heart Test Laboratories call Andrew Simpson at 682 237 7781 or check out https://heartsciences.com.

Heart Test Laboratories Investment Alerts

Heart Test generated a negative expected return over the last 90 days
Heart Test has high historical volatility and very poor performance
Heart Test has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 5.15 K. Net Loss for the year was (6.35 M) with profit before overhead, payroll, taxes, and interest of 2.35 K.
Heart Test Laboratories currently holds about 4.27 M in cash with (5.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52.
Heart Test has a poor financial position based on the latest SEC disclosures
Roughly 16.0% of the company shares are held by company insiders
Latest headline from globenewswire.com: HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

Heart Test Laboratories Upcoming and Recent Events

21st of March 2024
Upcoming Quarterly Report
View
31st of January 2024
Next Fiscal Quarter End
View

Heart Largest EPS Surprises

Earnings surprises can significantly impact Heart Test's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-03-14
2024-01-31-0.06-0.030.0350 
2023-12-14
2023-10-31-0.12-0.16-0.0433 
2023-07-19
2023-04-30-0.16-0.21-0.0531 
View All Earnings Estimates

Heart Test Environmental, Social, and Governance (ESG) Scores

Heart Test's ESG score is a quantitative measure that evaluates Heart Test's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Heart Test's operations that may have significant financial implications and affect Heart Test's stock price as well as guide investors towards more socially responsible investments.

Heart Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Goldman Sachs Group Inc2024-03-31
45.8 K
Geode Capital Management, Llc2024-03-31
42.3 K
Xtx Topco Ltd2024-03-31
24.3 K
Accurate Wealth Management, Llc2024-03-31
20.4 K
Alphastar Insurance Group Ltd2024-03-31
20 K
Chapin Davis Inc2024-03-31
15 K
Cubist Systematic Strategies, Llc2024-03-31
14.1 K
Wells Fargo & Co2024-03-31
453
Jpmorgan Chase & Co2024-03-31
10.0
Vanguard Group Inc2024-03-31
191.5 K
Tradition Wealth Management Llc2024-03-31
180.5 K
Note, although Heart Test's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Heart Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.66 M.

Heart Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(171.72)(163.13)
Return On Capital Employed(3.78)(3.59)
Return On Assets(171.72)(163.13)
Return On Equity-2.4 K-2.3 K

Management Efficiency

Heart Test Laboratories has return on total asset (ROA) of (0.5273) % which means that it has lost $0.5273 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5261) %, meaning that it created substantial loss on money invested by shareholders. Heart Test's management efficiency ratios could be used to measure how well Heart Test manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -163.13 in 2024. Return On Capital Employed is likely to gain to -3.59 in 2024. At this time, Heart Test's Net Tangible Assets are comparatively stable compared to the past year. Other Current Assets is likely to gain to about 40.5 K in 2024, whereas Total Assets are likely to drop slightly above 2.5 M in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 0.03  0.03 
Tangible Book Value Per Share 0.03  0.03 
Enterprise Value Over EBITDA(126.98)(133.33)
Price Book Value Ratio3.4 K3.5 K
Enterprise Value Multiple(126.98)(133.33)
Price Fair Value3.4 K3.5 K
Enterprise Value604.6 M537.4 M
The analysis of Heart Test's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Heart Test's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Heart Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Operating Margin
(103.77)
Beta
3.148
Return On Assets
(0.53)
Return On Equity
(1.53)

Technical Drivers

As of the 16th of July 2024, Heart Test retains the market risk adjusted performance of 1.31, and Risk Adjusted Performance of (0.07). Heart Test technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Heart Test Laboratories risk adjusted performance, variance, as well as the relationship between the Variance and potential upside to decide if Heart Test is priced fairly, providing market reflects its last-minute price of 4.03 per share. Given that Heart Test Laboratories has information ratio of (0.14), we strongly advise you to confirm Heart Test Laboratories's regular market performance to make sure the company can sustain itself at a future point.

Heart Test Laboratories Price Movement Analysis

Execute Study
The output start index for this execution was nine with a total number of output elements of fifty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Heart Test middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Heart Test Laboratories. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Heart Test Laboratories Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Heart Test insiders, such as employees or executives, is commonly permitted as long as it does not rely on Heart Test's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Heart Test insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Heart Test Outstanding Bonds

Heart Test issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Heart Test Laboratories uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Heart bonds can be classified according to their maturity, which is the date when Heart Test Laboratories has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Heart Test Predictive Daily Indicators

Heart Test intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Heart Test stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Heart Test Corporate Filings

8K
4th of June 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
22nd of May 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
16th of May 2024
An amendment to a previously filed Form 8-K
ViewVerify
8K
15th of May 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
10th of May 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
18th of March 2024
Other Reports
ViewVerify
10Q
14th of March 2024
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
S1
5th of March 2024
Report filed by companies planning on going public to register their securities with the U.S. Securities and Exchange Commission (SEC)
ViewVerify

Heart Test Forecast Models

Heart Test's time-series forecasting models are one of many Heart Test's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Heart Test's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Heart Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Heart Test prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Heart shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Heart Test. By using and applying Heart Stock analysis, traders can create a robust methodology for identifying Heart entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin-1.4 K-1.3 K
Operating Profit Margin-1.4 K-1.3 K
Net Loss-109.6 K-104.1 K
Gross Profit Margin 0.41  0.35 

Current Heart Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Heart analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Heart analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
3.6Strong Buy2Odds
Heart Test Laboratories current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Heart analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Heart stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Heart Test Laboratories, talking to its executives and customers, or listening to Heart conference calls.
Heart Analyst Advice Details

Heart Stock Analysis Indicators

Heart Test Laboratories stock analysis indicators help investors evaluate how Heart Test stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Heart Test shares will generate the highest return on investment. By understating and applying Heart Test stock analysis, traders can identify Heart Test position entry and exit signals to maximize returns.
Begin Period Cash Flow918.3 K
Long Term Debt500 K
Common Stock Shares OutstandingM
Total Stockholder Equity230.6 K
Total Cashflows From Investing Activities-18.3 K
Property Plant And Equipment Net590.7 K
Cash And Short Term Investments1.7 M
Cash1.7 M
Accounts Payable631.4 K
Net Debt-94.6 K
50 Day M A6.2295
Total Current Liabilities1.8 M
Other Operating Expenses6.1 M
Non Current Assets Total590.7 K
Stock Based Compensation248.3 K

Additional Tools for Heart Stock Analysis

When running Heart Test's price analysis, check to measure Heart Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heart Test is operating at the current time. Most of Heart Test's value examination focuses on studying past and present price action to predict the probability of Heart Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heart Test's price. Additionally, you may evaluate how the addition of Heart Test to your portfolios can decrease your overall portfolio volatility.